1.89
price up icon0.27%   0.01
 
loading

Finanzdaten der Hillevax Inc-Aktie (HLVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
23.59%
49.80
40.29 33.91 30.18 28.96
Interest Income/Expense
0.14%
0.727
0.726 0.717 0.50 0.449
Operating Income/Loss
23.59%
-49.80
-40.29 -33.91 -30.18 -28.96
Nonoperating Income/Loss
10.90%
2.968
3.331 2.096 2.282 2.07
Income/Loss From Continuing Operations Before Tax
26.70%
-46.83
-36.96 -31.82 -27.90 -26.89
Income/Loss From Continuing Operations After Tax
26.70%
-46.83
-36.96 -31.82 -27.90 -26.89
Net Income/Loss
26.70%
-46.83
-36.96 -31.82 -27.90 -26.89
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,966%
48.46
2.3455 39.04 37.95 37.75
Diluted Average Shares
1,966%
48.46
2.3455 39.04 37.95 37.75
Basic Earnings Per Share
24.36%
-0.97
-0.78 -0.81 -0.74 -0.71
Diluted Earnings Per Share
24.36%
-0.97
-0.78 -0.81 -0.74 -0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):